Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB-0742 in R/R Solid Tumors or NHL
NCT04718675Phase 2Terminated
- Sponsor
- Kronos Bio, Inc.
- Start
- Feb 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of Istisociclib in solid tumor, non-Hodgkin lymphoma (NHL), sponsored by Kronos Bio, Inc.. Started Feb 2021; status: terminated.
02
Drugs
Istisociclib
03
Conditions
solid tumornon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT04718675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718675.